About

Sigrid Saaler-Reinhardt, PhD, studied Biochemistry at the Free University of Berlin (Germany) and received her PhD in Cell Biology and Oncology from the Johannes Gutenberg-University of Mainz (Germany),
going on became a Professor of Molecular Genetics.

Prof Saaler-Reinhardt has more than 20 years of experience in academic research and the pharmaceutical industry, most of it at Midas Pharma, with responsibilities for R&D and intellectual property management, and subsequently for custom synthesis, biotechnology and drug device combination products. She is founder and consultant of her own company, EDUMO Consulting.

Contributions

INJECTION

A NOVEL INSTRUMENT TO STREAMLINE COMBINATION PRODUCT DEVELOPMENT

Daniel Primavessy, Sigrid Saaler-Reinhardt, Katarzyna Maksymowicz and Marie Stockton introduce the Gx Inbeneo^® platform simulator. This tool supports pharmaceutical companies in bridging formulation and medical device development processes, reducing time to market for patient-centric combination products.

More contributions

INJECTION

GX INBENEO^® – DEVELOPING AN AUTOINJECTOR THAT RESPONDS TO THE CHALLENGES OF BIOLOGICS

Daniel Primavessy, Sigrid Saaler-Reinhardt, Katarzyna Maksymowicz and Marie Stockton, Marketing Manager discuss how the Gx Inbeneo^® autoinjector from Gerresheimer was purpose designed to provide an effective, easy-to-use solution for the subcutaneous self-administration of sensitive biopharmaceuticals.

INJECTION

DEVELOPMENT OF A NEW HIGH-PERFORMANCE AUTOINJECTOR

Tom Oakley and Sigrid Saaler-Reinhardt discuss the development of the Midas Pharma’s NIS cartridge-based autoinjector.